Cargando…

Usefulness of the 6-minute walk test as a screening test for pulmonary arterial enlargement in COPD

PURPOSE: Pulmonary hypertension and exercise-induced oxygen desaturation (EID) influence acute exacerbation of COPD. Computed tomography (CT)-detected pulmonary artery (PA) enlargement is independently associated with acute COPD exacerbations. Associations between PA to aorta (PA:A) ratio and EID in...

Descripción completa

Detalles Bibliográficos
Autores principales: Oki, Yutaro, Kaneko, Masahiro, Fujimoto, Yukari, Sakai, Hideki, Misu, Shogo, Mitani, Yuji, Yamaguchi, Takumi, Yasuda, Hisafumi, Ishikawa, Akira
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5126000/
https://www.ncbi.nlm.nih.gov/pubmed/27920514
http://dx.doi.org/10.2147/COPD.S114497
_version_ 1782470040377884672
author Oki, Yutaro
Kaneko, Masahiro
Fujimoto, Yukari
Sakai, Hideki
Misu, Shogo
Mitani, Yuji
Yamaguchi, Takumi
Yasuda, Hisafumi
Ishikawa, Akira
author_facet Oki, Yutaro
Kaneko, Masahiro
Fujimoto, Yukari
Sakai, Hideki
Misu, Shogo
Mitani, Yuji
Yamaguchi, Takumi
Yasuda, Hisafumi
Ishikawa, Akira
author_sort Oki, Yutaro
collection PubMed
description PURPOSE: Pulmonary hypertension and exercise-induced oxygen desaturation (EID) influence acute exacerbation of COPD. Computed tomography (CT)-detected pulmonary artery (PA) enlargement is independently associated with acute COPD exacerbations. Associations between PA to aorta (PA:A) ratio and EID in patients with COPD have not been reported. We hypothesized that the PA:A ratio correlated with EID and that results of the 6-minute walk test (6MWT) would be useful for predicting the risk associated with PA:A >1. PATIENTS AND METHODS: We retrospectively measured lung function, 6MWT, emphysema area, and PA enlargement on CT in 64 patients with COPD. The patients were classified into groups with PA:A ≤1 and >1. Receiver-operating characteristic curves were used to determine the threshold values with the best cutoff points to predict patients with PA:A >1. RESULTS: The PA:A >1 group had lower forced expiratory volume in 1 second (FEV(1)), forced vital capacity (FVC), FEV(1):FVC ratio, diffusion capacity of lung carbon monoxide, 6MW distance, and baseline peripheral oxygen saturation (SpO(2)), lowest SpO(2), highest modified Borg scale results, percentage low-attenuation area, and history of acute COPD exacerbations ≤1 year, and worse BODE (Body mass index, airflow Obstruction, Dyspnea, and Exercise) index results (P<0.05). Predicted PA:A >1 was determined for SpO(2) during 6MWT (best cutoff point 89%, area under the curve 0.94, 95% confidence interval 0.88–1). SpO(2) <90% during 6MWT showed a sensitivity of 93.1, specificity of 94.3, positive predictive value of 93.1, negative predictive value of 94.3, positive likelihood ratio of 16.2, and negative likelihood ratio of 0.07. CONCLUSION: Lowest SpO(2) during 6MWT may predict CT-measured PA:A, and lowest SpO(2) <89% during 6MWT is excellent for detecting pulmonary hypertension in COPD.
format Online
Article
Text
id pubmed-5126000
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher Dove Medical Press
record_format MEDLINE/PubMed
spelling pubmed-51260002016-12-05 Usefulness of the 6-minute walk test as a screening test for pulmonary arterial enlargement in COPD Oki, Yutaro Kaneko, Masahiro Fujimoto, Yukari Sakai, Hideki Misu, Shogo Mitani, Yuji Yamaguchi, Takumi Yasuda, Hisafumi Ishikawa, Akira Int J Chron Obstruct Pulmon Dis Original Research PURPOSE: Pulmonary hypertension and exercise-induced oxygen desaturation (EID) influence acute exacerbation of COPD. Computed tomography (CT)-detected pulmonary artery (PA) enlargement is independently associated with acute COPD exacerbations. Associations between PA to aorta (PA:A) ratio and EID in patients with COPD have not been reported. We hypothesized that the PA:A ratio correlated with EID and that results of the 6-minute walk test (6MWT) would be useful for predicting the risk associated with PA:A >1. PATIENTS AND METHODS: We retrospectively measured lung function, 6MWT, emphysema area, and PA enlargement on CT in 64 patients with COPD. The patients were classified into groups with PA:A ≤1 and >1. Receiver-operating characteristic curves were used to determine the threshold values with the best cutoff points to predict patients with PA:A >1. RESULTS: The PA:A >1 group had lower forced expiratory volume in 1 second (FEV(1)), forced vital capacity (FVC), FEV(1):FVC ratio, diffusion capacity of lung carbon monoxide, 6MW distance, and baseline peripheral oxygen saturation (SpO(2)), lowest SpO(2), highest modified Borg scale results, percentage low-attenuation area, and history of acute COPD exacerbations ≤1 year, and worse BODE (Body mass index, airflow Obstruction, Dyspnea, and Exercise) index results (P<0.05). Predicted PA:A >1 was determined for SpO(2) during 6MWT (best cutoff point 89%, area under the curve 0.94, 95% confidence interval 0.88–1). SpO(2) <90% during 6MWT showed a sensitivity of 93.1, specificity of 94.3, positive predictive value of 93.1, negative predictive value of 94.3, positive likelihood ratio of 16.2, and negative likelihood ratio of 0.07. CONCLUSION: Lowest SpO(2) during 6MWT may predict CT-measured PA:A, and lowest SpO(2) <89% during 6MWT is excellent for detecting pulmonary hypertension in COPD. Dove Medical Press 2016-11-22 /pmc/articles/PMC5126000/ /pubmed/27920514 http://dx.doi.org/10.2147/COPD.S114497 Text en © 2016 Oki et al. This work is published and licensed by Dove Medical Press Limited The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed.
spellingShingle Original Research
Oki, Yutaro
Kaneko, Masahiro
Fujimoto, Yukari
Sakai, Hideki
Misu, Shogo
Mitani, Yuji
Yamaguchi, Takumi
Yasuda, Hisafumi
Ishikawa, Akira
Usefulness of the 6-minute walk test as a screening test for pulmonary arterial enlargement in COPD
title Usefulness of the 6-minute walk test as a screening test for pulmonary arterial enlargement in COPD
title_full Usefulness of the 6-minute walk test as a screening test for pulmonary arterial enlargement in COPD
title_fullStr Usefulness of the 6-minute walk test as a screening test for pulmonary arterial enlargement in COPD
title_full_unstemmed Usefulness of the 6-minute walk test as a screening test for pulmonary arterial enlargement in COPD
title_short Usefulness of the 6-minute walk test as a screening test for pulmonary arterial enlargement in COPD
title_sort usefulness of the 6-minute walk test as a screening test for pulmonary arterial enlargement in copd
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5126000/
https://www.ncbi.nlm.nih.gov/pubmed/27920514
http://dx.doi.org/10.2147/COPD.S114497
work_keys_str_mv AT okiyutaro usefulnessofthe6minutewalktestasascreeningtestforpulmonaryarterialenlargementincopd
AT kanekomasahiro usefulnessofthe6minutewalktestasascreeningtestforpulmonaryarterialenlargementincopd
AT fujimotoyukari usefulnessofthe6minutewalktestasascreeningtestforpulmonaryarterialenlargementincopd
AT sakaihideki usefulnessofthe6minutewalktestasascreeningtestforpulmonaryarterialenlargementincopd
AT misushogo usefulnessofthe6minutewalktestasascreeningtestforpulmonaryarterialenlargementincopd
AT mitaniyuji usefulnessofthe6minutewalktestasascreeningtestforpulmonaryarterialenlargementincopd
AT yamaguchitakumi usefulnessofthe6minutewalktestasascreeningtestforpulmonaryarterialenlargementincopd
AT yasudahisafumi usefulnessofthe6minutewalktestasascreeningtestforpulmonaryarterialenlargementincopd
AT ishikawaakira usefulnessofthe6minutewalktestasascreeningtestforpulmonaryarterialenlargementincopd